1. Home
  2. IMRN vs SRFM Comparison

IMRN vs SRFM Comparison

Compare IMRN & SRFM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • SRFM
  • Stock Information
  • Founded
  • IMRN 1994
  • SRFM 2011
  • Country
  • IMRN Australia
  • SRFM United States
  • Employees
  • IMRN N/A
  • SRFM N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • SRFM Transportation Services
  • Sector
  • IMRN Health Care
  • SRFM Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • SRFM Nasdaq
  • Market Cap
  • IMRN 15.0M
  • SRFM 62.8M
  • IPO Year
  • IMRN N/A
  • SRFM 2023
  • Fundamental
  • Price
  • IMRN $1.95
  • SRFM $6.13
  • Analyst Decision
  • IMRN Strong Buy
  • SRFM Hold
  • Analyst Count
  • IMRN 1
  • SRFM 2
  • Target Price
  • IMRN $5.00
  • SRFM $3.40
  • AVG Volume (30 Days)
  • IMRN 5.4K
  • SRFM 775.7K
  • Earning Date
  • IMRN 01-07-2025
  • SRFM 11-14-2024
  • Dividend Yield
  • IMRN N/A
  • SRFM N/A
  • EPS Growth
  • IMRN N/A
  • SRFM N/A
  • EPS
  • IMRN N/A
  • SRFM N/A
  • Revenue
  • IMRN $3,271,194.00
  • SRFM $118,212,000.00
  • Revenue This Year
  • IMRN N/A
  • SRFM $102.41
  • Revenue Next Year
  • IMRN N/A
  • SRFM $47.46
  • P/E Ratio
  • IMRN N/A
  • SRFM N/A
  • Revenue Growth
  • IMRN 171.67
  • SRFM 198.78
  • 52 Week Low
  • IMRN $1.59
  • SRFM $0.90
  • 52 Week High
  • IMRN $5.96
  • SRFM $11.48
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 43.88
  • SRFM 72.13
  • Support Level
  • IMRN $1.89
  • SRFM $2.64
  • Resistance Level
  • IMRN $2.09
  • SRFM $6.41
  • Average True Range (ATR)
  • IMRN 0.14
  • SRFM 0.81
  • MACD
  • IMRN -0.02
  • SRFM 0.20
  • Stochastic Oscillator
  • IMRN 9.09
  • SRFM 92.41

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About SRFM Surf Air Mobility Inc.

Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.

Share on Social Networks: